NGS is essential for this diagnosis, as it enables detection of at least one somatic mutation in genes commonly mutated in myeloid neoplasms (e.g., DNMT3A, TET2, ASXL1, SF3B1, SRSF2, etc.). Here, TET2 is linked to myeloid neoplasm.